We are live on ! Find out more
Cathie Wood

Cathie Wood ARK Investment Management

AUM $15.4B
1-Year Est. Return 50.29%
 

Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.

This Fund
S&P 500
This Quarter Est. Return
+18.48%
1 Year Est. Return
+50.29%
3 Year Est. Return
+250.43%
5 Year Est. Return
+91.72%
10 Year Est. Return
–
AUM
$347M
AUM Growth
+$72M
Cap. Flow
+$23.1M
Cap. Flow %
6.66%
Top 10 Hldgs %
43.67%
Holding
109
New
7
Increased
73
Reduced
23
Closed
5

Top Buys

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$5.43M
2
QCOM icon
Qualcomm
QCOM
+$4.78M
3
EDIT icon
Editas Medicine
EDIT
+$4.76M
4
TWTR
Twitter, Inc.
TWTR
+$4.47M
5
XLNX
Xilinx Inc
XLNX
+$4.33M

Top Sells

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$5.87M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$5.43M
3
NFLX icon
Netflix
NFLX
+$4.48M
4
DDD icon
3D Systems Corp
DDD
+$3.58M
5
NVDA icon
NVIDIA
NVDA
+$3.51M

Sector Composition

Rank Sector Weight
1 Technology 28.55%
2 Healthcare 26.21%
3 Communication Services 14.97%
4 Industrials 13.37%
5 Consumer Discretionary 11.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UCTT
76
Ultra Clean Holdings
UCTT
$3.46B
$312K 0.09%
18,514
-15,223
-45% -$202K
MZOR
77
DELISTED
Mazor Robotics Ltd.
MZOR
$311K 0.09%
10,448
+2,088
+25% +$49.2K
HWM icon
78
Howmet Aerospace
HWM
$108B
$282K 0.08%
13,959
+12,295
+739% +$242K
REGN icon
79
Regeneron Pharmaceuticals
REGN
$85.9B
$267K 0.08%
690
+68
+11% +$25.2K
APTV icon
80
Aptiv
APTV
$10B
$258K 0.07%
3,202
-1,333
-29% -$100K
FLEX icon
81
Flex
FLEX
$40.8B
$258K 0.07%
20,387
+4,077
+25% +$48.8K
INO icon
82
Inovio Pharmaceuticals
INO
$122M
$243K 0.07%
3,064
+462
+18% +$36.8K
ALNT icon
83
Allient
ALNT
$1.63B
$236K 0.07%
17,582
+8,132
+86% +$120K
UPS icon
84
United Parcel Service
UPS
$86.8B
$214K 0.06%
1,996
-349
-15% -$38.1K
AME icon
85
Ametek
AME
$54.9B
$210K 0.06%
3,891
+619
+19% +$32.6K
BOX icon
86
Box
BOX
$4.56B
$197K 0.06%
12,080
+245
+2% +$4.14K
INCY icon
87
Incyte
INCY
$25.9B
$193K 0.06%
1,442
-830
-37% -$106K
FARO
88
DELISTED
Faro Technologies
FARO
$190K 0.05%
5,301
+911
+21% +$33.2K
SYRS
89
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$131K 0.04%
825
+478
+138% +$58.3K
FPRX
90
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$128K 0.04%
3,551
+351
+11% +$15.5K
ADBE icon
91
Adobe
ADBE
$109B
$115K 0.03%
887
+118
+15% +$13.8K
CELG
92
DELISTED
Celgene Corp
CELG
$111K 0.03%
895
+88
+11% +$10.5K
NNDM
93
Nano Dimension
NNDM
$325M
$89K 0.03%
1,333
+266
+25% +$16.8K
NTRP icon
94
NextTrip
NTRP
$20M
$55K 0.02%
+89
New +$61.1K
CLLS
95
Cellectis
CLLS
$342M
$54K 0.02%
+2,254
New +$47.4K
JNCE
96
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$40K 0.01%
+1,811
New +$38.4K
EVGN icon
97
Evogene
EVGN
$8.89M
$39K 0.01%
738
+73
+11% +$3.8K
AAPL icon
98
Apple
AAPL
$4.51T
$34K 0.01%
+956
New +$31.5K
ATI icon
99
ATI
ATI
$28.2B
$33K 0.01%
1,835
+619
+51% +$11.6K
EMN icon
100
Eastman Chemical
EMN
$8.47B
$33K 0.01%
413
+91
+28% +$7.16K
1 2 3
4
5

Similar funds

Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return

Cathie Wood's Q1 2017 Portfolio in Review

As of Q1 2017, Cathie Wood held 109 positions worth $347M, up 26% from $275M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cathie Wood deployed $23.1M of net new capital in Q1 2017, opening 7 new positions and adding to 73 existing holdings. Its largest new stake was Editas Medicine: 229,922 shares worth $5.13M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Illumina, an estimated $5.87M trimmed.

  • Cathie Wood's largest Q1 2017 buy was Editas Medicine: 229,922 shares worth $5.13M.
  • Cathie Wood added most to Ionis Pharmaceuticals in Q1 2017, an estimated $5.43M increase.
  • Cathie Wood's biggest Q1 2017 reduction was Illumina, cutting an estimated $5.87M.
  • Cathie Wood fully exited Mentor Graphics Corp in Q1 2017, selling an estimated $512K.
  • Cathie Wood's ten largest holdings make up 44% of its $347M portfolio in Q1 2017.
  • Cathie Wood opened 7 new positions and closed 5 in Q1 2017.
  • Cathie Wood's portfolio value rose 26% quarter-over-quarter to $347M.

Based on ARK Investment Management's 13F filing for Q1 2017, filed 15 May 2017.